RPGLF (Regent Pacific Group) Equity-to-Asset: -11.63 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RPGLF Regent Pacific Group Ltd RPGLF
14 GF Score
Price $0.01
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group Equity-to-Asset?

Regent Pacific Group RPGLF 14 Equity-to-Asset is -11.63 as of Dec. 2025. GuruFocus rates RPGLF with a GF Score™ of 14/100. The stock has 7 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Regent Pacific Group ranks worse than 98.61% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Regent Pacific Group's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $-6.64 Mil. Regent Pacific Group's Total Assets for the quarter that ended in Dec. 2025 was $0.57 Mil. Therefore, Regent Pacific Group's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was -11.63.

The historical rank and industry rank for Regent Pacific Group's Equity-to-Asset or its related term are showing as below:

RPGLF' s Equity-to-Asset Range Over the Past 10 Years
Min: -11.63   Med: 0.62   Max: 0.89
Current: -11.63

During the past 13 years, the highest Equity to Asset Ratio of Regent Pacific Group was 0.89. The lowest was -11.63. And the median was 0.62.

RPGLF's Equity-to-Asset is ranked worse than
98.61% of 1008 companies
in the Drug Manufacturers industry
Industry Median: 0.61 vs RPGLF: -11.63

Regent Pacific Group  (OTCPK:RPGLF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Regent Pacific Group Equity-to-Asset Related Terms


Regent Pacific Group Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Regent Pacific Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regent Pacific Group Equity-to-Asset Chart

Regent Pacific Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.10 -0.56 -9.67 -11.63

Regent Pacific Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.56 -5.16 -9.67 -5.68 -11.63

RPGLF vs ZTS: Equity-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regent Pacific Group Equity-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's Equity-to-Asset falls into.


RPGLF
14GF Score
Regent Pacific Group Ltd RPGLF
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regent Pacific Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Regent Pacific Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=-6.641/0.571
=-11.63

Regent Pacific Group's Equity to Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

Equity to Asset (Q: Dec. 2025 )=Total Stockholders Equity/Total Assets
=-6.641/0.571
=-11.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of -11.63 mean?
Regent Pacific Group (RPGLF) has a Equity-to-Asset of -11.63 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Regent Pacific Group and its competitors. According to the industry distribution chart, Regent Pacific Group ranks #994 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 98.6%.
Is Regent Pacific Group's Equity-to-Asset too high?
Regent Pacific Group's current Equity-to-Asset is -11.63. Based on the distribution chart, Regent Pacific Group ranks #994 out of 1008 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Regent Pacific Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Regent Pacific Group's Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Regent Pacific Group ranks #994 out of 1008 companies for Equity-to-Asset. This places Regent Pacific Group in the lower half of its industry. The industry median Equity-to-Asset is 0.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Regent Pacific Group and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regent Pacific Group's current Equity-to-Asset is -11.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regent Pacific Group stock overvalued right now?
Regent Pacific Group (RPGLF) has a current Equity-to-Asset of -11.63. The current Equity-to-Asset is -11.63. Regent Pacific Group's overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Regent Pacific Group (RPGLF), the current Equity-to-Asset is -11.63 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regent Pacific Group Business Description

Other Exchanges 00575:Hong KongRPG:Germany
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
14GF Score

Get the complete analysis for RPGLF

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price